COVIDIEN EVERFLEX SELF-EXPANDING PERIPHERAL STENT WITH ENTRUST DELIVERY SYSTEM LONG; STENT, SUPERFICIAL FEMORAL ARTERY
|
Back to Search Results |
|
Model Number EVD35-06-150-120 |
Device Problems
Difficult to Remove (1528); Material Deformation (2976)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 08/25/2022 |
Event Type
malfunction
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Physician was attempting to use an everflex entrust self-expanding stent along with a 6fr sheath and a 0.035" non-medtronic guidewire during procedure to treat a moderately calcified lesion in the proximal superficial femoral artery (sfa) and an unknown artery.The vessel was moderately tortuous.The vessel diameter and lesion length are 6mm and 140mm respectively.No embolic protection use.There was no damage noted to packaging.There was issue noted when removing the device from hoop/tray, the device would not retract.It was reported that there was difficulty removing device prior to stent deployment.The lesion was pre dilated with 6mm evercross balloon.The device passed through a previously deployed stent.There was resistance encountered when advancing the device.The device was removed and stent was stretched.The stent remains implanted.No action was taken as a result of the deformation.There was no patient injury.
|
|
Manufacturer Narrative
|
Product analysis the device was returned with the red safety tab removed.The stent size was identified from the strain relief approx 100mm of the stent could be observed through the outer sheath damage was observed on the inner sheath beside the back luer hub and at approx.17.5cm ¿ 18.5cm from the back hub during functional testing the deployment wheel was rotated, and no advancement of the stent could be seen, the handle was opened, and it was found that the pullwire was broken the outer sheath was skived back, the stent was revealed and measured, approx.100mm of the stent was left intact.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|